Interferon-Beta 1a and SARS Coronavirus Replication
Abstract
A global outbreak of severe acute respiratory syndrome (SARS) caused by a novel coronavirus began in March 2003. The rapid emergence of SARS and the substantial illness and death it caused have made it a critical public health issue. Because no effective treatments are available, an intensive effort is under way to identify and test promising antiviral drugs. Here, we report that recombinant human interferon-beta 1a potently inhibits SARS coronavirus replication in vitro.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2004
- Accession Number
- ADA426745
Entities
People
- Christopher L. Karp
- Elizabeth A. Fritz
- John W. Huggins
- Lisa Hensley
- Peter B. Jahrling